February 6, 2013 7:32 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Bank of America downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral and raised the price target from $23.00 to $24.00.Bank of America noted, "We are downgrading Hologic to Neutral driven largely by valuation following a 22% increase since early December (vs the medical device group up 10%). While we're raising our PO slightly to $24 (from $23), we find it difficult to justify a higher valuation without expecting meaningful upside to 2013 estimates, which we believe is unlikely. On the top-line, both guidance and consensus for 2013 call for pro forma revenue growth of 5-6%, which implies an acceleration from the 3% level seen in fiscal Q1 to 6-8% in the back half of the year."Hologic closed at $22.75 on Tuesday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.